Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Organon & Co. (OGN)

Organon & Co. (OGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,540,685
  • Shares Outstanding, K 260,316
  • Annual Sales, $ 6,216 M
  • Annual Income, $ 187,000 K
  • EBIT $ 1,125 M
  • EBITDA $ 1,737 M
  • 60-Month Beta 0.67
  • Price/Sales 0.39
  • Price/Cash Flow 1.61
  • Price/Book 3.23

Options Overview Details

View History
  • Implied Volatility 106.43% (-8.00%)
  • Historical Volatility 93.09%
  • IV Percentile 98%
  • IV Rank 60.29%
  • IV High 148.31% on 03/20/26
  • IV Low 42.82% on 08/22/25
  • Expected Move (DTE 26) 1.97 (20.20%)
  • Put/Call Vol Ratio 0.17
  • Today's Volume 9,379
  • Volume Avg (30-Day) 6,874
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 146,704
  • Open Int (30-Day) 102,565
  • Expected Range 7.79 to 11.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.81
  • Number of Estimates 2
  • High Estimate $0.89
  • Low Estimate $0.74
  • Prior Year $0.95
  • Growth Rate Est. (year over year) -14.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.69 +71.53%
on 03/30/26
9.78 -0.20%
on 04/17/26
+3.37 (+52.74%)
since 03/17/26
3-Month
5.69 +71.53%
on 03/30/26
9.94 -1.81%
on 01/23/26
+1.00 (+11.42%)
since 01/16/26
52-Week
5.69 +71.53%
on 03/30/26
13.24 -26.31%
on 04/29/25
-1.36 (-12.23%)
since 04/17/25

Most Recent Stories

More News
Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will release its first quarter 2026 financial results on May 7, 2026,...

OGN : 9.76 (+4.61%)
Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis

The American Academy of Dermatology (AAD) provided a strong, evidence-based recommendation for the use of VTAMA cream, the only steroid-free topical treatment the AAD found to be supported by a high certainty...

OGN : 9.76 (+4.61%)
3 Reasons to Avoid OGN and 1 Stock to Buy Instead

3 Reasons to Avoid OGN and 1 Stock to Buy Instead

OGN : 9.76 (+4.61%)
S&P Futures Waver With All Eyes on Key U.S. Inflation Data, U.S.-Iran Talks Awaited

June S&P 500 E-Mini futures (ESM26) are trending down -0.02% this morning, swinging between gains and losses as investors cautiously await key U.S. inflation data to gauge the impact of higher oil prices...

ESM26 : 7,161.50s (+1.19%)
ADSK : 242.02 (-0.47%)
BF.B : 29.15 (-1.05%)
OGN : 9.76 (+4.61%)
NOW : 96.66 (+0.23%)
ZS : 134.68 (+0.26%)
BC.M.DX : 87.840 (+3.98%)
NKE : 46.03 (+0.72%)
SW.FP : 42.740 (+3.44%)
LITE : 894.07 (+0.32%)
AMZN : 250.56 (+0.34%)
MRVL : 139.69 (+4.74%)
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know

Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know

FTRE : 10.38 (+2.87%)
GH : 90.36 (+5.44%)
OGN : 9.76 (+4.61%)
CRL : 183.88 (+3.92%)
QDEL : 12.71 (+0.20%)
Organon accelerates Women's Health progress across Asia Pacific with 2026 Her Health Grants

SYDNEY , March 27, 2026 /PRNewswire/ -- Organon Asia Pacific Cluster today announced the 2026 Her Health Grant recipients for the Asia Pacific region, marking a significant milestone in efforts to...

OGN : 9.76 (+4.61%)
Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age

VTAMA demonstrated early and consistent response rates in disease severity and itch improvements, measured by the Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™) and Peak Pruritus-Numeric...

OGN : 9.76 (+4.61%)
3 Cash-Producing Stocks We’re Skeptical Of

3 Cash-Producing Stocks We’re Skeptical Of

CPB : 20.99 (+0.24%)
TRU : 78.25 (+3.45%)
OGN : 9.76 (+4.61%)
3 Value Stocks We Approach with Caution

3 Value Stocks We Approach with Caution

REZI : 40.28 (+2.68%)
OGN : 9.76 (+4.61%)
PEBO : 34.36 (+2.08%)
1 Stock Under $10 to Own for Decades and 2 That Underwhelm

1 Stock Under $10 to Own for Decades and 2 That Underwhelm

LESL : 1.8200 (unch)
GDYN : 5.95 (-0.83%)
OGN : 9.76 (+4.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J.

See More

Key Turning Points

3rd Resistance Point 10.53
2nd Resistance Point 10.16
1st Resistance Point 9.96
Last Price 9.76
1st Support Level 9.38
2nd Support Level 9.01
3rd Support Level 8.81

See More

52-Week High 13.24
Fibonacci 61.8% 10.36
Last Price 9.76
Fibonacci 50% 9.47
Fibonacci 38.2% 8.58
52-Week Low 5.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.